Keyphrases
New Patients
100%
Deacetylase
100%
Deacetylase Inhibitor
100%
Patient-derived Tumors
100%
Metaplastic Breast Carcinoma
100%
Patient-derived Xenograft
33%
Gene Expression
22%
Tumor Growth
22%
Breast Cancer
22%
Associated Genes
22%
Synergistic Effect
22%
Inhibitor Treatment
22%
Therapeutic Discovery
22%
Basal-like
22%
Breast Carcinoma Cells
22%
Growth Rate
11%
Cell Population
11%
Tumor
11%
Cell Migration
11%
Cancer Model
11%
Oncology
11%
Romidepsin
11%
Histone Deacetylase Inhibitor (HDACi)
11%
Targeted Therapeutics
11%
Rapid Growth
11%
Epithelial-to-mesenchymal Transition
11%
MEK1
11%
Metastasis
11%
Mesenchymal Phenotype
11%
Tumor Metastasis
11%
Reduced Cell
11%
Cell Morphology
11%
Epithelial-mesenchymal Transition
11%
Cellular Expression
11%
Patient-derived Cell Line
11%
Lung Metastasis
11%
Inhibitor Therapy
11%
Circulating Tumor Cells
11%
Breast Cancer Subtypes
11%
Aggressive Subtypes
11%
Discovery Research
11%
Conventional Chemotherapy
11%
Transwell Migration
11%
Similar Features
11%
Organoids
11%
Growth Characteristics
11%
Implanted Tumor
11%
Cell Biomass
11%
Migratory Phenotype
11%
Cell Sphere
11%
Panobinostat
11%
Migration Population
11%
Rare Subtype
11%
Biochemistry, Genetics and Molecular Biology
Gene Expression
100%
Tumor Progression
100%
Cell Cycle
100%
Mesenchymal-Epithelial Transition
100%
Histone Deacetylase
50%
Cell Migration
50%
Explant
50%
Romidepsin
50%
Medicine and Dentistry
Neoplasm
100%
Breast Carcinoma
100%
Xenograft
37%
Carcinoma Cell
25%
Gene Expression
25%
Tumor Progression
25%
Metastatic Carcinoma
25%
Mesenchymal-Epithelial Transition
25%
Cell Cycle
25%
Basal Like Breast Cancer
25%
Malignant Neoplasm
12%
Breast Cancer
12%
Oncology
12%
In Vitro
12%
Cell Migration
12%
Cancer Model
12%
Romidepsin
12%
Histone Deacetylase Inhibitor
12%
Lung Metastasis
12%
Circulating Tumor Cell
12%
Organoid
12%
Panobinostat
12%
Chemotherapy
12%